India, July 26 -- MDxHealth SA (MDXH), a precision diagnostics company, on Friday announced receipt of an additional notification letter from The Nasdaq Stock Market LLC, reiterating the company's minimum bid price deficiency.
The company previously received a notification letter on June 30, 2026, from the Listing Qualifications Department, disclosing the company's violation of Nasdaq Listing Rule 5550 (b)(2), which requires listed securities to maintain a minimum market value of US$35 million and Nasdaq Listing Rule 5810(c)(3)(C) provides that a failure to meet the minimum market value requirement exists if the deficiency continues for a period of 30 consecutive business days.
Based on the market value of the Company from June 1, 2026, t...